Gerresheimer presents strong results

Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, brought financial year 2013 to a successful close.

– 2013 was a rewarding year for us. We met all the targets we set ourselves. At the beginning of financial year 2014, we sharpened our organi-zation’s customer focus. We are investing in highly promising growth projects, further improvements in quality and the internationalization of our business. These are important steps in setting the course for our future, said Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG.

Gerresheimer increased revenues in financial year 2013 (December 1, 2012 to November 30, 2013) by 3.8% to EUR 1,265.9m. At constant exchange rates, this corresponds to growth of 5.8%. Business with the pharma industry once more showed strong growth and broad cyclical resilience. Revenue gains were likewise generated with cosmetics packaging.

Sales volumes were solely down in the area of laboratory glassware due to weak market demand in North America. Gerresheimer generates some 83% of revenues with products for the pharma and healthcare industry. The Company increased adjusted EBITDA by 4.1% in financial year 2013 to EUR 249.8m. At constant exchange rates and including EUR 7.5m in other operating income, this corresponds to EBITDA of EUR 254.0m.

{{ visitor.ipAccess.member.name }}

{{ visitor.ipAccess.corporateClient.name }}

{{ visitor.person.name }}

Gerresheimer presents strong results

Företagens egna nyheter

Mest läst

Senaste nytt

Utvalda artiklar

Utvalda nyheter från förstasidan

Förpackningsindustrins framtid – så här diskuterar branschen

Plastpåseskatten försvann: utebliven prissänkning i två av tre butikskedjor

Metsä Board investerar 700 miljoner i fabrik

AI hittar rätt emballage

Mångmiljardförvärv: Två förpackningsjättar blir en dominant

Andra Nordiska Medier

Nyhetsbrev

Sänd till en kollega